Abstract
Purpose
Malignant pleural effusion is a common complication of primary and metastatic pleural malignancies. It is usually managed by drainage and pleurodesis, but there is no consensus as to the best method of pleurodesis. We compared the effectiveness, side effects, and cost of different chemical pleurodesis agents used in patients with malignant pleural effusion.
Methods
Between January 1990 and December 2001, 108 patients with malignant pleural effusion underwent chemical pleurodesis in our department. Thoracoscopy was performed in 64 patients (59%), a minithoracotomy in 18 (17%), tube thoracostomy in 11 (10%), and a small-bore catheter was inserted in 15 (14%). Talc was used in 68 (63%) patients, tetracycline in 26 (24%), and bleomycin in 14 (13%). Talc was instilled by insufflation during surgery after drainage, whereas tetracycline and bleomycin were instilled via tube or catheter for pleural analgesia.
Results
Talc resulted in significantly earlier tube and catheter removal, after an average 4.1 days versus 5.1 days after tetracyline, and 6.3 days after bleomycin (P = 0.026, P = 0.001, respectively). A significantly lower reaccumulation ratio in 90 days was achieved by the talc group, with nine (13.2%) patients, representing an 86.8% success rate, than in the tetracyline and bleomycin groups, with seven (26.7%) and five (35.7%) patients, respectively, representing 73.8% and 64.3% success rates (P = 0.04).
Conclusions
Talc resulted in the earliest expansion, minimal drainage, and the earliest tube and catheter removal.
Similar content being viewed by others
References
G Antunes E Neville (2000) ArticleTitleManagement of malignant pleural effusions Thorax 55 981–3 Occurrence Handle10.1136/thorax.55.12.981 Occurrence Handle11083880
EC Leuallen DT Carr (1955) ArticleTitlePleural effusion. A statistical study of 436 patients N Engl J Med 252 79–83 Occurrence Handle13223986
D Cheng RM Rodrigez EA Perkett J Rogers G Bienvenu U Lappalainen et al. (1999) ArticleTitleVascular endothelial growth factor in pleural fluid Chest 116 760–5 Occurrence Handle10.1378/chest.116.3.760 Occurrence Handle10492284
A Kraft K Weindel A Ochs J Zmija P Schumacher C Unger et al. (1999) ArticleTitleVascular endothelial growth factor in the sera and effusions with malignant and nonmalignant disease Cancer 85 178–87 Occurrence Handle10.1002/(SICI)1097-0142(19990101)85:1<178::AID-CNCR25>3.0.CO;2-7 Occurrence Handle9921991
TR Gravelyn MK Michelson BH Gross RG Sitrin (1987) ArticleTitleTetracycline pleurodesis for malignant pleural affusion: 10 year retrospective study Cancer 59 1973–7 Occurrence Handle2436744
B Chernow SA Sahn (1977) ArticleTitleCarcinomatous involvement of the pleura Am J Med 63 695–702 Occurrence Handle10.1016/0002-9343(77)90154-1 Occurrence Handle930945
RH Adler I Sayek (1976) ArticleTitleTreatment of malignant pleural effusion: a method using tube thoracostomy and talc Ann Thorac Surg 22 8–15 Occurrence Handle938141
LA Parker GC Charnock DJ Delany (1989) ArticleTitleSmall bore catheter drainage and sclerotherapy for malignant effusions Cancer 64 1218–21 Occurrence Handle2766220
L Kennedy VW Rusch C Strange RJ Ginsberg SA Sahn (1994) ArticleTitlePleurodesis using talc slurry Chest 106 342–6 Occurrence Handle7774299
J-R Viallat F Rey P Astoul C Boutin (1996) ArticleTitleThoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases Chest 110 1387–93 Occurrence Handle8989050
A Bernard RB Dompsure O Hagry JP Favre (2002) ArticleTitleEarly and late mortality after pleurodesis for malignant pleural effusion Ann Thorac Surg 74 213–7 Occurrence Handle10.1016/S0003-4975(02)03599-3 Occurrence Handle12118761
DG Lorch L Gordon S Wooten JF Cooper C Strange SA Sahn (1988) ArticleTitleEffect of patient positioning on distribution of tetracycline in the pleural space during pleurodesis Chest 93 527–9 Occurrence Handle2830079
R Hochleither (1990) TalcMinerals EditionNumber1 Barron’s Educational Series Hong Kong
PB Walker-Renard LM Vaughan SA Sahn (1994) ArticleTitleChemical pleurodesis for malignant pleural effusions Ann Intern Med 120 56–64 Occurrence Handle8250457
VW Rush (1995) ArticleTitleA proposed new international TNM staging system for malignant pleural mesothelioma Chest 108 1122–8 Occurrence Handle7555126
AP Yim ATC Chan TW Lee IYP Wan JKS Ho (1996) ArticleTitleThoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion Ann Thorac Surg 62 1655–8 Occurrence Handle10.1016/S0003-4975(96)00808-9 Occurrence Handle8957368
A York P Bondoc P Bach N Vander (1999) ArticleTitleTalc pneumonitis: incidence, clinical features and outcome Chest 116 IssueIDSuppl 358–9
RW Light (2000) ArticleTitleTalc should not be used for pleurodesis Am J Respir Crit Care Med 162 2024–6 Occurrence Handle11112104
AH Diacon C Wyser CT Bolliger M Tamm M Pless AP Perruchoud et al. (2000) ArticleTitleProspective randomized comparison of thoracoscopic talc poudrage under local anesthesia versus bleomycin instillation for pleurodesis in malignant pleural effusions Am J Respir Crit Care Med 162 1445–9 Occurrence Handle11029359
JE Rinaldo GR Owens RM Rogers (1983) ArticleTitleAdult respiratory distress syndrome following intrapleural instillation of talc J Thorac Cardiovasc Surg 85 523–6 Occurrence Handle6834872
DH Rehse RW Aye MG Florence (1999) ArticleTitleRespiratory failure following talc pleurodesis Am J Surg 177 437–40 Occurrence Handle10.1016/S0002-9610(99)00075-6 Occurrence Handle10365887
EC Werebe R Pazetti JR Milanez de Campos PP Fernandez VL Capelozzi FB Jatene FS Vargas (1999) ArticleTitleSystemic distribution of talc after intrapleural administration in rats Chest 115 190–3 Occurrence Handle10.1378/chest.115.1.190 Occurrence Handle9925083
L Landvater WR Hix M Mills RS Siegal BL Aaron (1988) ArticleTitleMalignant pleural effusion treated by tetracycline sclerotherapy. A comparison of single vs repeated instillation Chest 93 1196–8 Occurrence Handle3371098
HW Wallach (1975) ArticleTitleIntrapleural tetracycline for malignant pleural effusions Chest 68 510–2 Occurrence Handle1175409
R Felletti C Ravazonni (1983) ArticleTitleIntrapleural Corynebacterium parvum for malignant pleural effusions Thorax 38 22–4 Occurrence Handle6845257
M Petrou D Kaplan P Goldstraw (1995) ArticleTitleManagement of recurrent malignant pleural effusions Cancer 75 801–5 Occurrence Handle7530167
O Genc M Petrou G Ladas P Golstraw (2000) ArticleTitleThe long-term morbidity of pleuroperitoneal shunts in the management of recurrent malignant effusions Eur J Cardiothorac Surg 18 143–6 Occurrence Handle10.1016/S1010-7940(00)00422-X Occurrence Handle10925221
I Baeyens RG Berrisford (2001) ArticleTitlePleuroperitoneal shunts and tumor seeding J Thorac Cardiovasc Surg 121 813–8 Occurrence Handle10.1067/mtc.2001.111377 Occurrence Handle11279426
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kilic, D., Akay, H., Kavukçu, Ş. et al. Management of Recurrent Malignant Pleural Effusion with Chemical Pleurodesis. Surg Today 35, 634–638 (2005). https://doi.org/10.1007/s00595-005-2996-5
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00595-005-2996-5